Compugen Ltd. (CGEN) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, thank you for joining us today. Welcome to CompuGen's first quarter 2025 results conference call. At this time, all participants are in listen-only mode. An audio webcast of this call is available in the Investors section of CompuGen's website, www.cgen.com. As a reminder, today's call is being recorded. I would now like to introduce Yvonne Naughton, Vice President, Head of Investor Relations and Corporate Communications, Yvonne, please go ahead. Thank you, operator, and thank you all for joining us on the call today. Joining me from Compogen for the prepared remarks are Dr. Anak Cohen-Diag, President and Chief Executive Officer, and David Zimmerman, Chief Financial Officer. Dr. Michelle Moller, Chief Medical Officer, and Dr. Ivana Burr, Chief Scientific Officer, will join us for the Q&A. Before we begin, we would like to remind you that during this call, the company may make projections of forward-looking statements regarding future events, business outlook, development efforts and their potential outcome, the company's discovery platform, anticipated progress and plans, results and timelines for our programs, financial and accounting-related matters, as well as statements regarding our cash position and cash runway. We wish to caution you that such statements reflect only the company's current beliefs, expectations and assumptions. but actual results, performance, or achievements of the company may differ materially. These statements are subject to known and unknown risks and uncertainties, and we refer you to our SEC filings for more details on these risks, including the company's most recent annual report on Form 20-F. The company undertakes no obligation to update projections and forward-looking statements in the future. And with that, I'll...